Lung cancer screening

BSI is also currently developing Pulmolisa for the screening of lung cancer in combination with LDCT and clinical trials are under way.

It is recommended to perform annual blood tests over 45 years of age, especially for those who have a high risk of developing lung cancer, such as smokers, people working with or exposed to carcinogens (lead and lead derivatives, welding gases, atrazine, diesel exhaust, asbestos, radon), and those with a family history of lung cancer.